Axinn Obtains Global Antitrust Clearance for Thermo Fisher Scientific Inc.’s $13.6 billion Acquisition
January 31, 2014
Axinn was global coordinating antitrust counsel to Thermo Fisher Scientific Inc. (“Thermo Fisher”) in its $13.6 billion acquisition of Life Technologies Corporation.
Axinn worked with Slaughter & May to help Thermo Fisher secure global clearance across nine different jurisdictions (Federal Trade Commission, European Commission, PRC’s MOFCOM, Canada, Japan, South Korea, Russia, Australia and New Zealand).
The Axinn and Slaughter & May teams successfully navigated nine regulatory reviews of more than fifty (50) different product areas involving complex life science products, which included a Second Request from the Federal Trade Commission and a Phase II investigation from MOFCOM. Axinn and Slaughter & May secured global convergence on remedies through a single US$1 billion divestiture to General Electric Company (as an upfront buyer), tailored to cover only three product areas, and local supply and pricing remedies in China for two additional product areas.
The Axinn team included partners John Harkrider, Michael Keeley, Mark Alexander and Daniel Bitton; counsel Morris Bloom; and associate Daniel Oakes.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
Benchmark Litigation Honors Axinn Partners on 2026 “40 & Under List”
Awards & Recognitions
Litigation & Trials
Axinn Partner Rebecca Clegg Named to Hartford Business Journal’s 2026 40 Under Forty
Awards & Recognitions
Intellectual Property
What Happens in Vegas Stays in Vegas: Third Circuit Parts Ways with Ninth Circuit and Reinstates Atlantic City Algorithmic-Pricing Claim
Axinn Viewpoints
Antitrust
What Should Directors Be Asking? Antitrust in the Boardroom
Podcast
Antitrust
Axinn Represents Modular in $4 Billion Acquisition by Qualcomm
Deals & Cases
Antitrust
Will New DOJ Timing Agreement Deliver Faster Merger Clearances?
Axinn Viewpoints
Antitrust
Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
Byline Articles
Antitrust
Women Leaders in Life Sciences Law
Speaking Engagement
Litigation & Trials